Literature DB >> 17404593

Xom interacts with and stimulates transcriptional activity of LEF1/TCFs: implications for ventral cell fate determination during vertebrate embryogenesis.

Hong Gao1, Bin Wu, Roger Giese, Zhenglun Zhu.   

Abstract

LEF1/TCFs are high mobility group box-containing transcriptional factors mediating canonical Wnt/beta-catenin signaling during early embryogenesis and tumorigenesis. Beta-catenin forms a complex with LEF1/TCFs and transactivates LEF1/TCF-mediated transcriptions during dorsalization. Although LEF-mediated transcription is also implicated in ventralization, the underlying molecular mechanism is not well understood. Using the vertebrate Xenopus laevis model system, we found that Xom, which is a ventralizing homeobox protein with dual roles of transcriptional activation and repression, forms a complex with LEF1/TCF through its homeodomain and transactivates LEF1/TCF-mediated transcription through its N-terminal transactivation domain (TAD). Our data show that Xom lacking the N-terminal TAD fails to transactivate ventral genes, such as BMP4 and Xom itself, but retains the ability to suppress transcriptional activation of dorsal gene promoters, such as the Goosecoid promoter, indicating that transactivation and repression are separable functions of Xom. It has been postulated that Xom forms a positive re-enforcement loop with BMP4 to promote ventralization and to suppress dorsal gene expression. Consistent with an essential role of Xom transactivation of LEF1/TCFs during early embryogenesis, we found that expression of the dominant-negative Xom mutant that lacks the TAD fails to re-enforce the ventral signaling of BMP4 and causes a catastrophic effect during gastrulation. Our data suggest that the functional interaction of Xom and LEF1/TCF-factors is essential for ventral cell fate determination and that LEF1/TCF factors may function as a point of convergence to mediate the combined signaling of Wnt/beta-catenin and BMP4/Xom pathways during early embryogenesis.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17404593     DOI: 10.1038/cr.2007.20

Source DB:  PubMed          Journal:  Cell Res        ISSN: 1001-0602            Impact factor:   25.617


  11 in total

1.  Suppression of homeobox transcription factor VentX promotes expansion of human hematopoietic stem/multipotent progenitor cells.

Authors:  Hong Gao; Xiaoming Wu; Yan Sun; Shuanhu Zhou; Leslie E Silberstein; Zhenglun Zhu
Journal:  J Biol Chem       Date:  2012-07-12       Impact factor: 5.157

2.  The homeobox transcription factor VentX controls human macrophage terminal differentiation and proinflammatory activation.

Authors:  Xiaoming Wu; Hong Gao; Weixiong Ke; Roger W Giese; Zhenglun Zhu
Journal:  J Clin Invest       Date:  2011-06-13       Impact factor: 14.808

3.  VentX expression in tumor-associated macrophages promotes phagocytosis and immunity against pancreatic cancers.

Authors:  Yi Le; Hong Gao; William Richards; Lei Zhao; Ronald Bleday; Thomas Clancy; Zhenglun Zhu
Journal:  JCI Insight       Date:  2020-07-23

4.  VentX trans-activates p53 and p16ink4a to regulate cellular senescence.

Authors:  Xiaoming Wu; Hong Gao; Weixiong Ke; Martin Hager; Sheng Xiao; Michael R Freeman; Zhenglun Zhu
Journal:  J Biol Chem       Date:  2011-02-16       Impact factor: 5.157

5.  Homeobox transcription factor VentX regulates differentiation and maturation of human dendritic cells.

Authors:  Xiaoming Wu; Hong Gao; Ronald Bleday; Zhenglun Zhu
Journal:  J Biol Chem       Date:  2014-04-04       Impact factor: 5.157

6.  Conservation and diversification of an ancestral chordate gene regulatory network for dorsoventral patterning.

Authors:  Iryna Kozmikova; Jana Smolikova; Cestmir Vlcek; Zbynek Kozmik
Journal:  PLoS One       Date:  2011-02-03       Impact factor: 3.240

7.  Homeobox protein VentX induces p53-independent apoptosis in cancer cells.

Authors:  Hong Gao; Bin Wu; Yi Le; Zhenglun Zhu
Journal:  Oncotarget       Date:  2016-06-28

8.  The homeobox protein VentX reverts immune suppression in the tumor microenvironment.

Authors:  Yi Le; Hong Gao; Ronald Bleday; Zhenglun Zhu
Journal:  Nat Commun       Date:  2018-06-05       Impact factor: 14.919

Review 9.  Ventx Family and Its Functional Similarities with Nanog: Involvement in Embryonic Development and Cancer Progression.

Authors:  Shiv Kumar; Vijay Kumar; Wenchang Li; Jaebong Kim
Journal:  Int J Mol Sci       Date:  2022-03-01       Impact factor: 5.923

10.  Sample prep for proteomics of breast cancer: proteomics and gene ontology reveal dramatic differences in protein solubilization preferences of radioimmunoprecipitation assay and urea lysis buffers.

Authors:  Lambert C M Ngoka
Journal:  Proteome Sci       Date:  2008-10-24       Impact factor: 2.480

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.